Literature DB >> 7986160

Lipolysis in burned patients is stimulated by the beta 2-receptor for catecholamines.

D N Herndon1, T T Nguyen, R R Wolfe, S P Maggi, G Biolo, M Muller, R E Barrow.   

Abstract

OBJECTIVE: To determine if the cardiovascular effects of excessive catecholamines could be selectively blocked in severely burned patients without adversely affecting protein or fat kinetics.
DESIGN: Prospective cohort study.
SETTING: A large tertiary care referral center in Galveston, Tex. PATIENTS: Sixteen patients with greater than 40% body surface area burns.
INTERVENTIONS: Patients were randomly selected to receive propranolol hydrochloride, a nonselective beta 1- and beta 2-blocker, or metoprolol tartrate, a selective beta 1-blocker. MAIN OUTCOME MEASURES: Heart rate; rate-pressure product; rate of appearance of urea, glucose, and leucine; and leucine oxidation were measured before and after selective or nonselective beta-adrenergic blockade.
RESULTS: Propranolol and metoprolol caused a significant decrease in heart rate, from a mean (+/- SD) of 143 +/- 15 to 115 +/- 11 and from 147 +/- 17 to 120 +/- 9 beats per minute, respectively, during the 5-day study period. Neither the rate of appearance of urea nor the rate of urea production were significantly altered by propranolol or metoprolol therapy. Only propranolol produced a significant decrease (P < .05) in the rate of appearance of glycerol, from a mean (+/- SD) of 5.54 +/- 0.62 to 3.07 +/- 0.7 mumol/kg per minute. The rate of appearance of leucine, used as an index of total body protein catabolism, was not significantly altered by either beta-blocker.
CONCLUSIONS: Selective beta 1-adrenergic blockade did not reduce lipolysis; however, a beta 1- and beta 2-adrenergic blockade significantly reduced lipolysis. Thus, the increased lipolysis, characteristic of severely burned patients, is caused by stimulation of the beta 2-adrenergic receptors for catecholamines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986160     DOI: 10.1001/archsurg.1994.01420360091012

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  32 in total

1.  Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.

Authors:  David N Herndon; Charles D Voigt; Karel D Capek; Paul Wurzer; Ashley Guillory; Andrea Kline; Clark R Andersen; Gordon L Klein; Ronald G Tompkins; Oscar E Suman; Celeste C Finnerty; Walter J Meyer; Linda E Sousse
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

2.  The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly.

Authors:  Robert E Barrow; Robert R Wolfe; Mohan R Dasu; Laura N Barrow; David N Herndon
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

3.  Glucose Control in Severely Burned Patients Using Metformin: An Interim Safety and Efficacy Analysis of a Phase II Randomized Controlled Trial.

Authors:  Marc G Jeschke; Abdikarim Abdullahi; Marjorie Burnett; Sarah Rehou; Mile Stanojcic
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

Review 4.  The cornerstones and directions of pediatric burn care.

Authors:  S E Wolf; M Debroy; D N Herndon
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

5.  Severe Burn Injury Induces Thermogenically Functional Mitochondria in Murine White Adipose Tissue.

Authors:  Craig Porter; David N Herndon; Nisha Bhattarai; John O Ogunbileje; Bartosz Szczesny; Csaba Szabo; Tracy Toliver-Kinsky; Labros S Sidossis
Journal:  Shock       Date:  2015-09       Impact factor: 3.454

Review 6.  Current problems in burn hypermetabolism.

Authors:  Christian Sommerhalder; Elizabeth Blears; Andrew J Murton; Craig Porter; Celeste Finnerty; David N Herndon
Journal:  Curr Probl Surg       Date:  2019-11-11       Impact factor: 1.909

7.  The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.

Authors:  Marc G Jeschke; Celeste C Finnerty; Oscar E Suman; Gabriela Kulp; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

8.  Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged.

Authors:  A Aarsland; D Chinkes; R R Wolfe; R E Barrow; S O Nelson; E Pierre; D N Herndon
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

9.  Morphological Changes in Subcutaneous White Adipose Tissue After Severe Burn Injury.

Authors:  Manish Kumar Saraf; David N Herndon; Craig Porter; Tracy Toliver-Kinsky; Ravi Radhakrishnan; Tony Chao; Maria Chondronikola; Labros S Sidossis
Journal:  J Burn Care Res       Date:  2016 Mar-Apr       Impact factor: 1.845

Review 10.  Is propranolol of benefit in pediatric burn patients?

Authors:  Celeste C Finnerty; David N Herndon
Journal:  Adv Surg       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.